(Q35648549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

review article

1 reference

title

Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

author name string

Bell SJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Lemoine NR

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

497-503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

18 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Why did p53 gene therapy fail in ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Tissue-specific expression of an anti-proliferative hybrid transgene from the human smooth muscle alpha-actin promoter suppresses smooth muscle cell proliferation and neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

The role of adenovirus E4orf4 protein in viral replication and cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Effects of adenovirus-mediated expression of p27Kip1, p21Waf1 and p16INK4A in cell lines derived from t(2;5) anaplastic large cell lymphoma and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Human ARF binds E2F1 and inhibits its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha ) and inhibits HIF-1-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Human ARF protein interacts with topoisomerase I and stimulates its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

PTEN controls tumor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302238

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14762396%20AND%20SRC:MED&resulttype=core&format=json

release_dzucercoonemndmt7e27ivkm2m

18 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dzucercoonemndmt7e27ivkm2m

24 November 2022

mapped directly with Wikidata item

1 reference